Vertigo Tablets 250gm
Kent Vertigo Tablets 250gm are a homoeopathic oral preparation from Kent Pharma traditionally used as supportive care for dizziness, motion sickness, and various types of vertigo, including faintness associated with vertigo, nausea, and balance-related discomfort.
The current formula contains Ambra D6, Cocculus D4, Conium D3, and Petroleum D8. Kent Pharma positions the tablets for different types of vertigo, including dizziness associated with travel, looking downward from a height, head movement, nausea, and feelings of heaviness or emptiness in the head.
Vertigo can have many causes, including inner-ear disorders, BPPV, vestibular neuritis, Ménière's disease, migraine, medicines, low blood pressure, anaemia, cardiovascular conditions, or neurological disease.
Kent Vertigo Tablets should therefore be considered complementary homoeopathic support and should not replace professional assessment or established treatment for persistent or severe vertigo.
Active Ingredients – Manufacturer-Listed Formula:
China, Chamomilla, Ferrum phosphoricum, Ipecacuanha, Natrium sulphuricum, and Veratrum album are traditionally associated in homoeopathic practice with diarrhoeal complaints, abdominal cramping, nausea, vomiting, digestive upset, weakness following fluid loss, and colicky symptoms.
These traditional associations do not establish proven antidiarrhoeal, antibacterial, antiviral, antiparasitic, antiemetic, rehydrating, dysentery-treating, or infection-curing effects.
Ingredient Summary
| Ingredient | Potency |
|---|---|
| China | 6X |
| Chamomilla | 6X |
| Ferrum phosphoricum | 8X |
| Ipecacuanha | 12X |
| Natrium sulphuricum | 12X |
| Veratrum album | 8X |
Pack size: 250 g.
Dosage form: Homoeopathic Tablets.
Product enlistment number: 0079830500.
The supplied information does not provide the individual quantitative amounts of the active ingredients, tablet base, binders, sweeteners, lactose or other sugars, flavouring agents, preservatives, or complete excipient composition.
The ingredient name China 6X should be retained exactly as supplied unless the current physical container or manufacturer documentation provides a fuller pharmacopoeial or botanical name.
The supplied information also does not state the tablet count contained in the 250 g pack. This should be confirmed from the physical container rather than estimated from the pack weight.
Because this preparation may be given to children, the physical label should be checked carefully for minimum-age guidance, tablet administration instructions, sugar or lactose content, and any manufacturer-specific paediatric precautions.
Disclaimer
At SuperWellness, we make every effort to ensure that product information on our website is accurate and up to date. However, manufacturers may change product ingredients, packaging, directions, or other details without notice, and actual product information may vary from what is displayed online. The information provided on this website is for general informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease, nor should it replace professional medical advice. Customers are advised to read all product labels, warnings, and instructions carefully before use and consult a qualified healthcare professional regarding any medical concerns.
